We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amdocs Q2 Earnings Top Estimates, Stock Falls on Dim Q3 Profit Outlook
Read MoreHide Full Article
Amdocs Limited (DOX - Free Report) reported better-than-expected second-quarter fiscal 2025 results. The company posted non-GAAP earnings of $1.78 per share, which came above management’s guidance of $1.67-$1.73 and increased 14.1% year over year. The figure also exceeded the Zacks Consensus Estimate of $1.71.
In the trailing four quarters, DOX’s earnings surpassed the Zacks Consensus Estimate thrice while matching once, with an average surprise of 0.1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Amdocs’ second-quarter revenues of $1.23 billion surpassed the consensus mark of $1.12 billion. However, compared with the year-ago quarter, revenues were down 9.4% on a reported basis due to the phase-out of certain business activities. Excluding the effect of phase-out business activities, revenues were up 4% year over year in pro forma constant currency.
Despite reporting better-than-expected second-quarter results, shares of Amdocs fell 3.5% during Wednesday’s extended trading session as EPS guidance for the third quarter fell short of the Zacks Consensus Estimate.
Amdocs reported a decline in revenues across all regions due to the phase-out of certain business activities. North America reported revenues of $738.3 million (65% of total revenues), which plunged 10.3% year over year.
Europe revenues (16% of total revenues) of $180.7 million decreased 2.2% year over year. Rest of the World (RoW) revenues (19% of total revenues) declined 12% year over year to $209.2 million. Our model estimates for North America, Europe and RoW were pinned at $729.4 million, $166 million and $230.6 million, respectively.
Managed services revenues rose 3.7% year over year to $747 million. The company ended the second quarter of fiscal 2025 with a 12-month backlog of $4.17 billion, up $30 million sequentially. Our model estimates for managed services revenues and backlog were pegged at $675 million and $3.87 billion, respectively.
The non-GAAP operating income increased 4.7% year over year to $240.1 million, while the operating margin expanded 290 basis points (bps) to 21.3%.
Amdocs’ Balance Sheet & Cash Flow
Amdocs had cash and short-term investments of $324 million as of March 31, 2025, compared with $349 million as of Dec. 31, 2024. Long-term debt was $646.6 million as of March 31, 2025, almost flat to the Dec. 31, 2024 level.
During the second quarter, it generated an operating cash flow of $172 million and a free cash flow of $156 million. In the first half of fiscal 2025, it generated operating cash flow and free cash flow of $278 million and $235 million, respectively.
Amdocs’ Guidance Update
Amdocs initiated guidance for the third quarter and updated the outlook for full-fiscal 2025. For the third quarter, the company expects revenues to be in the band of $1.11-$1.15 billion (mid-point $1.13 billion). The Zacks Consensus Estimate for revenues is pegged at $1.13 billion, suggesting a year-over-year decline of 9.3%.
Amdocs expects non-GAAP earnings per share to be between $1.68 and $1.74. The Zacks Consensus Estimate for earnings is pegged at $1.75 per share, indicating a year-over-year rise of 8%.
For fiscal 2025, Amdocs trimmed revenue decline rate guidance to 9.1-10.9% from 8.4-11.6% forecasted previously. However, the mid-point of the new guidance range remained unchanged at a decline of 10%. The Zacks Consensus Estimate for revenues is pegged at $4.52 billion, suggesting a year-over-year decline of 9.8%.
Non-GAAP operating margin is still anticipated to be in the range of 21.1-21.7% for fiscal 2025. Non-GAAP earnings are still expected to grow in the band of 6.5-10.5%. The Zacks Consensus Estimate for earnings is pegged at $6.97 per share, indicating a year-over-year rise of 8.2%.
The company continues to expect free cash flow between $710 million and $730 million.
The Zacks Consensus Estimate for Impinj’s 2025 earnings has been revised upward by 21 cents to $1.68 per share over the past 30 days, and suggests a year-over-year decrease of 20.4%. Impinj shares have plunged 38.4% over the past year.
The Zacks Consensus Estimate for StoneCo’s 2025 earnings has moved upward by 19 cents to $1.38 per share in the past 30 days, reflecting 2.2% year-over-year growth. StoneCo shares have plunged 20.8% in the trailing 12 months.
The Zacks Consensus Estimate for Broadcom’s fiscal 2025 earnings has been revised upward by 4 cents to $6.60 per share in the past 60 days, suggesting an increase of 35.5% from fiscal 2024’s reported figure. Broadcom shares have rallied 56.8% over the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Amdocs Q2 Earnings Top Estimates, Stock Falls on Dim Q3 Profit Outlook
Amdocs Limited (DOX - Free Report) reported better-than-expected second-quarter fiscal 2025 results. The company posted non-GAAP earnings of $1.78 per share, which came above management’s guidance of $1.67-$1.73 and increased 14.1% year over year. The figure also exceeded the Zacks Consensus Estimate of $1.71.
In the trailing four quarters, DOX’s earnings surpassed the Zacks Consensus Estimate thrice while matching once, with an average surprise of 0.1%. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Amdocs’ second-quarter revenues of $1.23 billion surpassed the consensus mark of $1.12 billion. However, compared with the year-ago quarter, revenues were down 9.4% on a reported basis due to the phase-out of certain business activities. Excluding the effect of phase-out business activities, revenues were up 4% year over year in pro forma constant currency.
Despite reporting better-than-expected second-quarter results, shares of Amdocs fell 3.5% during Wednesday’s extended trading session as EPS guidance for the third quarter fell short of the Zacks Consensus Estimate.
Amdocs Limited Price, Consensus and EPS Surprise
Amdocs Limited price-consensus-eps-surprise-chart | Amdocs Limited Quote
Amdocs’ Q2 Details
Amdocs reported a decline in revenues across all regions due to the phase-out of certain business activities. North America reported revenues of $738.3 million (65% of total revenues), which plunged 10.3% year over year.
Europe revenues (16% of total revenues) of $180.7 million decreased 2.2% year over year. Rest of the World (RoW) revenues (19% of total revenues) declined 12% year over year to $209.2 million. Our model estimates for North America, Europe and RoW were pinned at $729.4 million, $166 million and $230.6 million, respectively.
Managed services revenues rose 3.7% year over year to $747 million. The company ended the second quarter of fiscal 2025 with a 12-month backlog of $4.17 billion, up $30 million sequentially. Our model estimates for managed services revenues and backlog were pegged at $675 million and $3.87 billion, respectively.
The non-GAAP operating income increased 4.7% year over year to $240.1 million, while the operating margin expanded 290 basis points (bps) to 21.3%.
Amdocs’ Balance Sheet & Cash Flow
Amdocs had cash and short-term investments of $324 million as of March 31, 2025, compared with $349 million as of Dec. 31, 2024. Long-term debt was $646.6 million as of March 31, 2025, almost flat to the Dec. 31, 2024 level.
During the second quarter, it generated an operating cash flow of $172 million and a free cash flow of $156 million. In the first half of fiscal 2025, it generated operating cash flow and free cash flow of $278 million and $235 million, respectively.
Amdocs’ Guidance Update
Amdocs initiated guidance for the third quarter and updated the outlook for full-fiscal 2025. For the third quarter, the company expects revenues to be in the band of $1.11-$1.15 billion (mid-point $1.13 billion). The Zacks Consensus Estimate for revenues is pegged at $1.13 billion, suggesting a year-over-year decline of 9.3%.
Amdocs expects non-GAAP earnings per share to be between $1.68 and $1.74. The Zacks Consensus Estimate for earnings is pegged at $1.75 per share, indicating a year-over-year rise of 8%.
For fiscal 2025, Amdocs trimmed revenue decline rate guidance to 9.1-10.9% from 8.4-11.6% forecasted previously. However, the mid-point of the new guidance range remained unchanged at a decline of 10%. The Zacks Consensus Estimate for revenues is pegged at $4.52 billion, suggesting a year-over-year decline of 9.8%.
Non-GAAP operating margin is still anticipated to be in the range of 21.1-21.7% for fiscal 2025. Non-GAAP earnings are still expected to grow in the band of 6.5-10.5%. The Zacks Consensus Estimate for earnings is pegged at $6.97 per share, indicating a year-over-year rise of 8.2%.
The company continues to expect free cash flow between $710 million and $730 million.
DOX’s Zacks Rank & Stocks to Consider
Currently, Amdocs carries a Zacks Rank #3 (Hold).
Impinj (PI - Free Report) (PI - Free Report) , StoneCo (STNE - Free Report) and Broadcom (AVGO - Free Report) are some top-ranked stocks that investors can consider in the broader Zacks Computer and Technology sector. While Impinj and StoneCo each sports a Zacks Rank #1 (Strong Buy) at present, Broadcom carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Impinj’s 2025 earnings has been revised upward by 21 cents to $1.68 per share over the past 30 days, and suggests a year-over-year decrease of 20.4%. Impinj shares have plunged 38.4% over the past year.
The Zacks Consensus Estimate for StoneCo’s 2025 earnings has moved upward by 19 cents to $1.38 per share in the past 30 days, reflecting 2.2% year-over-year growth. StoneCo shares have plunged 20.8% in the trailing 12 months.
The Zacks Consensus Estimate for Broadcom’s fiscal 2025 earnings has been revised upward by 4 cents to $6.60 per share in the past 60 days, suggesting an increase of 35.5% from fiscal 2024’s reported figure. Broadcom shares have rallied 56.8% over the past year.